These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy. Alonzi T; Aiello A; Petrone L; Najafi Fard S; D'Eletto M; Falasca L; Nardacci R; Rossin F; Delogu G; Castilletti C; Capobianchi MR; Ippolito G; Piacentini M; Goletti D Cells; 2021 Dec; 11(1):. PubMed ID: 35011614 [TBL] [Abstract][Full Text] [Related]
11. In Vitro Anti-SARS-CoV-2 Activity of Selected Metal Compounds and Potential Molecular Basis for Their Actions Based on Computational Study. Cirri D; Marzo T; Tolbatov I; Marrone A; Saladini F; Vicenti I; Dragoni F; Boccuto A; Messori L Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944502 [TBL] [Abstract][Full Text] [Related]
12. Rapid in vitro assays for screening neutralizing antibodies and antivirals against SARS-CoV-2. Park JG; Oladunni FS; Chiem K; Ye C; Pipenbrink M; Moran T; Walter MR; Kobie J; Martinez-Sobrido L J Virol Methods; 2021 Jan; 287():113995. PubMed ID: 33068703 [TBL] [Abstract][Full Text] [Related]
14. Lectin from Auth J; Fröba M; Große M; Rauch P; Ruetalo N; Schindler M; Morokutti-Kurz M; Graf P; Dolischka A; Prieschl-Grassauer E; Setz C; Schubert U Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638545 [TBL] [Abstract][Full Text] [Related]
15. Construction of a Noninfectious SARS-CoV-2 Replicon for Antiviral-Drug Testing and Gene Function Studies. Nguyen HT; Falzarano D; Gerdts V; Liu Q J Virol; 2021 Aug; 95(18):e0068721. PubMed ID: 34191580 [TBL] [Abstract][Full Text] [Related]
16. Antiviral Activity of Influenza A Virus Defective Interfering Particles against SARS-CoV-2 Replication In Vitro through Stimulation of Innate Immunity. Rand U; Kupke SY; Shkarlet H; Hein MD; Hirsch T; Marichal-Gallardo P; Cicin-Sain L; Reichl U; Bruder D Cells; 2021 Jul; 10(7):. PubMed ID: 34359926 [TBL] [Abstract][Full Text] [Related]
17. Glycyrrhizin Effectively Inhibits SARS-CoV-2 Replication by Inhibiting the Viral Main Protease. van de Sand L; Bormann M; Alt M; Schipper L; Heilingloh CS; Steinmann E; Todt D; Dittmer U; Elsner C; Witzke O; Krawczyk A Viruses; 2021 Apr; 13(4):. PubMed ID: 33918301 [TBL] [Abstract][Full Text] [Related]
18. Resveratrol and Pterostilbene Inhibit SARS-CoV-2 Replication in Air-Liquid Interface Cultured Human Primary Bronchial Epithelial Cells. Ter Ellen BM; Dinesh Kumar N; Bouma EM; Troost B; van de Pol DPI; van der Ende-Metselaar HH; Apperloo L; van Gosliga D; van den Berge M; Nawijn MC; van der Voort PHJ; Moser J; Rodenhuis-Zybert IA; Smit JM Viruses; 2021 Jul; 13(7):. PubMed ID: 34372541 [TBL] [Abstract][Full Text] [Related]
19. A Hepatitis B Virus-Derived Peptide Can Inhibit Infection of Human Lung Cells with SARS-CoV-2 in a Type-1 Interferon-Dependent Manner. Choi YM; Jeong H; Park U; Cho NH; Kim BJ Viruses; 2021 Jun; 13(7):. PubMed ID: 34202029 [TBL] [Abstract][Full Text] [Related]
20. Amantadine Inhibits SARS-CoV-2 In Vitro. Fink K; Nitsche A; Neumann M; Grossegesse M; Eisele KH; Danysz W Viruses; 2021 Mar; 13(4):. PubMed ID: 33804989 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]